Healthcare -
Biotechnology - NASDAQ - US
$ 5.435
-1.54 %
$ 372 M
Market Cap
-0.95
P/E
PHAT - STOCK-BASED COMPENSATION
Stock-based Compensation PHAT - Phathom Pharmaceuticals, Inc.
45 M
LAST VALUE
63.65%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR